🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2.5 Gram(s) Serving Size
14 Servings
Fat/Fatty Acid Product Type
25% Evidence Coverage

Supplement Facts — Evidence Check

Calories
10 Calorie(s)
Total Fat
1 Gram(s) (2% DV)
Total Carbohydrates
1 Gram(s)
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 500mg UL 3000mg

Other Ingredients

Docosahexaenoic Acid Corn Oil Water Xylitol Gum Arabic Natural Flavors Citric Acid Xanthan Gum Potassium Sorbate Beta Carotene Menthol

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years) Children (All) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Squeeze anywhere! After practice With lunch Sweet treat On the bus

Directions: Take one packet daily with or without food. Tear or cut perforation and squeeze directly into mouth, onto a spoon, or add to food or drink. Do not freeze or heat.

⚠️ Warnings & Precautions

Manufactured in a facility which processes egg, fish.

🧪 Formulation Notes

Does not contain dairy, yeast, wheat, or gluten.

The DHA found in Coromega squeeze is a gift for good nutrition. Our formula is blended with tasty orange flavor.

This means a peasant taste, smoothness and ease of delivery that your whole family will love!

Additional Information

14 single serving packets (2.5g)

Product Details

DSLD Entry Date 2023-09-25
Product Type Fat/Fatty Acid
Form Other (e.g. tea bag)
Brand Coromega
DSLD ID 296863
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →